Structure–Activity Relationship for the Oxadiazole Class of Antibiotics
Citations Over TimeTop 10% of 2015 papers
Abstract
The structure-activity relationship (SAR) for the newly discovered oxadiazole class of antibiotics is described with evaluation of 120 derivatives of the lead structure. This class of antibiotics was discovered by in silico docking and scoring against the crystal structure of a penicillin-binding protein. They impair cell-wall biosynthesis and exhibit activities against the Gram-positive bacterium Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA) and vancomycin-resistant and linezolid-resistant S. aureus. 5-(1H-Indol-5-yl)-3-(4-(4-(trifluoromethyl)phenoxy)phenyl)-1,2,4-oxadiazole (antibiotic 75b) was efficacious in a mouse model of MRSA infection, exhibiting a long half-life, a high volume of distribution, and low clearance. This antibiotic is bactericidal and is orally bioavailable in mice. This class of antibiotics holds great promise in recourse against infections by MRSA.
Related Papers
- → Efficacy of Linezolid Alone or in Combination with Vancomycin for Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus(2003)77 cited
- → Efficacy of Linezolid Versus Vancomycin in the Treatment of Methicillin-Resistant Staphylococcus aureus Discitis(2006)24 cited
- → Comparison of In-vitro Activities of Linezolid and Vancomycin against Staphylococcus aureus Isolated from A Tertiary Care Hospital(2014)11 cited
- Post-antibiotic effect of linezolid and vancomycin against methicillin-resistant Staphyloccus aureus(2013)
- Comparison of Linezolid vs.Vancomycin in the Treatment of Retention Catheterization Infection Induced by MRSA(2011)